About the Product

Description


Quinshell 300 Tablet contains Quinine 300mg, an antimalarial agent indicated for the treatment of malaria and symptomatic relief of fever associated with Plasmodium infections. It helps in reducing parasite load and controlling high fever effectively.

Quinine works by interfering with the parasite’s ability to metabolize hemoglobin, leading to the destruction of Plasmodium species in the bloodstream. Its proven efficacy ensures rapid symptom resolution and is widely used in both adult and pediatric malaria management.

For distributors and healthcare suppliers, Quinshell 300 Tablet is a high-demand antimalarial therapy product, commonly supplied to hospitals, clinics, endemic regions, and government malaria control programs. Seasonal malaria incidence drives consistent demand year-round.

Adding Quinshell 300 Tablet to your antimalarial therapy segment creates strong opportunities in pharmacies, hospitals, clinics, export markets, and third-party manufacturing. Its clinical reliability, prescriber trust, and essential role in malaria management make it a valuable addition to pharmaceutical distribution portfolios.


Common side effects may include nausea, vomiting, headache, dizziness, or mild gastrointestinal discomfort. Rare but serious side effects include cardiac arrhythmias, severe hypersensitivity reactions, cinchonism (tinnitus, visual disturbances), or blood disorders. Immediate medical attention should be sought if severe symptoms occur.

Quinshell 300 Tablet is indicated for the treatment of uncomplicated and severe malaria, particularly due to Plasmodium falciparum, as prescribed by a healthcare professional. It may also be used in combination therapy as recommended in local malaria treatment guidelines.

Quinshell 300 Tablet should be taken exactly as prescribed, and the full course must be completed to prevent resistance. Caution is advised in patients with heart conditions, liver or kidney disease, or a history of hypersensitivity to quinine. Alcohol and other medications affecting heart rhythm should be avoided during therapy.

Store Quinshell 300 Tablet in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and do not use beyond the expiry date printed on the packaging.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Quinine 300mg Tablet in the PCD pharma franchise market?

Quinine 300mg Tablet has demand in the anti-infective, tropical medicine, and specialty healthcare segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on specialty pharmaceutical portfolios.

Why should medical distributors include Quinine 300mg Tablet in their product range?

Medical distributors and agencies can benefit from demand for specialized antimalarial therapy under strict medical supervision. Quinine 300mg is an antimalarial medication used in the treatment of specific malaria infections according to established medical guidelines Commonly prescribed for the management of certain forms of malaria, particularly when recommended by healthcare professionals as part of an appropriate treatment regimen Plays an important role in infectious disease management in regions where malaria remains a healthcare concern Requires careful dosing, monitoring, and adherence to the prescribed treatment schedule Frequently utilized in hospitals, specialty clinics, and healthcare institutions involved in infectious disease care Widely prescribed by physicians, infectious disease specialists, and healthcare professionals This strengthens a comprehensive anti-infective and specialty care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Quinine 300mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from specialty healthcare market opportunities, institutional demand, reliable supply chain support, and attractive margins in the anti-infective segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.